Home » Newsletters » BioWorld

BioWorld

March 10, 1999

View Archived Issues

Correction (Article Corrected in Database)

Other News To Note

Xoma Told To Continue Phase III Neuprex Study

Biosafety Protocol Fails To Pass Muster In Columbia

Wild-Card Genes Cruise Genome; Randomly, Rarely Disrupt Gene Sequences

ImClone Moves Into Phase III With C225, Gets $5M Milestone

Genentechs Next-Generation TPA Product Proves Equal To Activase In Phase III Trial